首页> 外国专利> NITROXY GROUP-CONTAINING BENZYLAMINE DERIVATIVES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES, AS WELL AS INCREASED INTRA-OCULAR PRESSURE,

NITROXY GROUP-CONTAINING BENZYLAMINE DERIVATIVES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES, AS WELL AS INCREASED INTRA-OCULAR PRESSURE,

机译:含氮基的苄胺衍生物及其在治疗心血管疾病以及增加眼内压中的用途,

摘要

The present invention relates to compounds of the general formula (I) and salts thereof.;(7);Wherein A1 is C1-15Alkylene, C5-7Of cycloalkylene or di-C1-4Alkylene-C5-7Cycloalkane; R1 is hydrogen, C1-7Alkyl or C3-8/RTI R2 is hydrogen, C1-7Alkyl, C3-8Or R 1 and R 2 are taken together with the nitrogen atom to form unsubstituted or substituted 5 RTI-, 6-or 7-membered heterocycle; A2 is C1-15Alkylene, C5-7Of cycloalkylene or di-C1-4Alkylene-C5-7Cycloalkane; Y is R3, NH2, NH-R4 or S-R5, the-substituted picolide group is C1-4Alkyl, C1-4Alkoxy and hydroxy, the substituted piperidine group is substituted with one or two identical or different substituents selected from the group consisting of C1-4Alkyl, C1-4Alkoxy and hydroxy, the substituted piperazine group is substituted by one or more of the same or different substituents selected from the group consisting of C1-4May be substituted at the 2-, 3-, 5-, or 6-position, and the 4-position may be substituted with C1-4Alkyl, C1-4Alkoxycarbonyl, C1-4Phenyl substituted with R6, R7 and R8, phenyl-substituted with R6, R7 and R8 in the phenyl group1-4-alkyl, benzoyl, picolinoyl, nicotinoyl, isonicotinoyl, optionally halogen or C RTI ID = 0.0 1-4-alkyl substituted benzhydryl and the R4 group, the substituted morpholin group is substituted with one or two identical or different C1-4Substituted homofiperazines are substituted with an alkyl group of C1-4-alkyl, C1-4-alkoxycarbonyl, C1-4-alkylcarbonyl, phenyl substituted with R6, R7 and R8, phenyl-C-substituted with R6, R7 and R8 in the phenyl group1-4-benzoyl substituted in the alkyl and phenyl group with R6, R7 and R8; R3 is furyl, naphthyl, tetrahydronaphthyl,-O-Al-ONO2Substituted phenyl or phenyl substituted by R6, R7 and R8; R4 is C1-7-alkyl /RTI or substituted-CH2-CH (OH)-(CH2O)p-Ar; R5 is R6, R7 and R8 substituted phenyl, R6, R7 and R8 are substituted phenyl-C1-4-alkyl, optionally halogen or C RTI ID = 0.0 1-4Alkyl-substituted benzhydryl, dibenzo-C5-7-cycloalkanyl, dibenzocycloheptenyl or benzo-pyrido-C5-7-cycloalkanyl; R6 is hydrogen, C1-4-alkyl, C1-4-alkoxy, C1-4-alkoxy, C1-4-alkylcarbonyl, halogenamino, mono-or di-(C1-4Alkyl) amino or nitro; R7 is hydrogen, C1-4-alkyl, C1-4-alkoxy, halogen or nitro; R 8 is hydrogen or trifluoromethyl; P is an integer of 0 or 1; Ar is a hydrocarbon ring system of fully or partially unsaturated monocyclic (containing 5 to 6 ring atoms) or bicyclic (containing 9 to 10 ring atoms) wherein 1, 2 or 3 carbon atoms contain nitrogen (N ), Oxygen (O) or sulfur (S) may be inserted, and C1-4-alkyl, C1-4-alkoxy, C1-4-alkylthio, C1-4Alkoxy-C1-4-alkyl, C1-4-alkoxy-C1-4-alkoxy, C3-4-alkenyl, C3-4-alkenyloxy, C3-8-cycloalkyl, C5-10-cycloalkylalkoxyalkyl, C RTI ID = 0.0 1-4-alkylcarbonyl, C1-4-alkylcarbonylamino, carbamoyl, carbamoyl-C1-4-alkyl, halogen, hydroxy, oxonitro, cyan C1-4-alkylsulfonamido, amino, mono-or di-(C1-4-alkyl) amino, ureido, mono-or di-(C1-4-alkyl) ureido, mono-or di-(C3-8-cycloalkyl) ureido, trifluoromethyl, fully or partially fluoro substituted C1-4-alkoxy, C1-4-alkoxycarbonyl, tetrahydrofurfuryloxy or morpholino, or a pharmaceutically acceptable salt thereof. These compounds are useful in the treatment of cardiovascular diseases and elevated intraocular pressure.
机译:(7);其中A1是C 1-15 亚烷基,C 5-7 亚环烷基或二-C 1-4 亚烷基-C 5-7 环烷烃; R 1是氢,C 1-7 烷基或C 3-8 1-7 烷基,C 3-8 或R 1和R 2与氮原子一起形成未取代或取代的5-,6-或7-元杂环; A2为C 1-15 亚烷基,亚环烷基的C 5-7 或二-C 1-4 亚烷基-C 5- 7 环烷烃; Y为R 3,NH 2 ,NH-R4或S-R5,取代的甲基吡啶基为C 1-4 烷基,C 1-4 烷氧基和羟基,取代的哌啶基团被一个或两个相同或不同的选自C 1-4 烷基,C 1-4 的取代基取代烷氧基和羟基被取代的哌嗪基被选自C 1-4 的一个或多个相同或不同的取代基取代。可以在2-,3-,5-位被取代或6位,且4位可以被C 1-4 烷基,C 1-4 烷氧羰基,C 1-4 苯基上的 1-4 -烷基,苯甲酰基,吡啶啉基,烟酰基,异烟酰基,任选的卤素或C <被R6,R7和R8取代的苯基,被R6,R7和R8取代的苯基其中, 1-4 -烷基取代的二苯甲基和R4基团,该取代的吗啉基团被一个或两个相同或不同的C < Sub> 1-4 取代的高哌嗪被C 1-4 -烷基,C 1-4 -烷氧羰基,C 的烷基取代1-4 -烷基羰基,被R6,R7和R8取代的苯基,在烷基中被取代的苯基 1-4 -苯甲酰基中的苯基-C被R6,R7和R8取代R6,R7和R8为苯基。 R3是呋喃基,萘基,四氢萘基,-O-Al-ONO 2 取代的苯基或被R6,R7和R8取代的苯基。 R 4是C 1-7 -烷基或取代的-CH 2 -CH(OH)-(CH 2 O)< Sub> p -Ar; R 5是R 6,R 7和R 8取代的苯基,R 6,R 7和R 8是取代的苯基-C 1-4烷基,任选地是卤素或C 1-4烷基。 / Sub>烷基取代的苯甲基,二苯并-C 5-7 -环烷基,二苯并环庚烯基或苯并-吡啶基-C 5-7 -环烷基; R 6是氢,C 1-4 -烷基,C 1-4 -烷氧基,C 1-4 -烷氧基,C 1-4 -烷基羰基,卤代氨基,单或二-(C 1-4 烷基)氨基或硝基; R7是氢,C 1-4 -烷基,C 1-4 -烷氧基,卤素或硝基; R 8为氢或三氟甲基; P是0或1的整数; Ar是完全或部分不饱和的单环(含5至6个环原子)或双环(含9至10个环原子)的烃环系统,其中1、2或3个碳原子包含氮(N),氧(O)或硫可以插入(S),并且C 1-4 -烷基,C 1-4 -烷氧基,C 1-4 -烷硫基, C 1-4 烷氧基-C 1-4 -烷基,C 1-4 -烷氧基-C 1-4 -烷氧基,C 3-4 -烯基,C 3-4 -烯基氧基,C 3-8 -环烷基,C 5-10 -环烷基烷氧基烷基,C 1-4 -烷基羰基,C 1-4 -烷基羰基氨基,氨基甲酰基,氨基甲酰基-C 1-4 -烷基,卤素,羟基,氧硝基,氰基C 1-4 -烷基磺酰胺基,氨基,单-或二-(C 1-4 < / Sub>-烷基)氨基,脲基,单或二-(C 1-4 -烷基)脲基,单或二-(C 3-8 -环烷基)脲基,三氟甲基,全或部分氟取代的C 1-4 -烷氧基,C 1-4 -烷氧基羰基,四氢氢呋喃氧基或吗啉代或其药学上可接受的盐。这些化合物可用于治疗心血管疾病和眼内压升高。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号